Tetra Radar · FDA Approvals · Decision date

cytisinicline: FDA decision date

Achieve Life Sciences Inc. (ACHV) · 20 June 2026

In September 2025, we announced that the FDA accepted for review our NDA for cytisinicline as a treatment of nicotine dependence for smoking cessation in adults and assigned a PDUFA targeted action date of June 20, 2026.

Source: 10-Q of 12 May 2026

The date has passed; Tetra Radar has not recorded an approval.

Achieve Life Sciences Inc. on Tetra Radar

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.